Explore By Subject Area   

R&D Leadership Summit

Date: Mar 10, 2025 - Mar 11, 2025

Location: Manalapan, FL


Each year, the Conference Forum holds the R&D Leadership Summit®a private event for primarily senior-level R&D executives and CEOs from mid to large pharma and biotech companies, to address timely and relevant issues impacting R&D decision-making. The 2024 dates were March 4-5 at the Eau Palm Beach in Manalapan, Florida. The 2024 theme was focused on accelerating R&D productivity enhancement opportunities.

Huge thanks to lead advisors Fred Hassan, Managing Director, Healthcare, Warburg Pincus, Thomas Koestler, PhD, Executive Director, Vatera Health Care Partners, Mathai Mammen, MD, PhD, CEO, FogPharma, Alise Reicin, MD, CEO, Tectonic Therapeutics, Mark Simon, Advisor, Stifel and Sun Pharma, David Reese, MD, EVP and Chief Technology Officer, Amgen, Andy Plump, MD, PhD, President, R&D, Takeda and Ron Cohen, MD, President and CEO, Acorda Therapeutics for their guidance and support on the program agenda.

Dr John Reed and Fred Hassan

image placeholder

Dr Anna Barker and Dr Laura Esserman

image placeholder
image placeholder
image placeholder

Dr Meeta Chatterjee and Dr David Reese

We are grateful for the support and participation
​​​​​​​from advisors and attendees

Houman Ashrafian BM, BCh, PhD
Executive Vice President, Global Head of R&D Sanofi

Ann D Barker, PhD, FAACR

Chief Strategy Officer, The Ellison Institute

Roy Baynes, MD, PhD
EVP and Chief Medical Officer, Eikon Therapeutics, Inc

Jeffrey Berkowitz
CEO and Director, Real Endpoints

Azad Bonni, MD, PhD
SVP, Global Head of Neuroscience and Rare Diseases, Roche Pharma Research & Early Development

Amitabh Chandra, PhD
Professor of Business Administration and Public Policy, Harvard University

Meeta Chatterjee, PhD
Chief Strategy Officer, Sun Pharmaceutical Industries, Inc

Ron Cohen, MD, PhD
President and CEO, Acorda Therapeutics

Rena Conti, PhD
Associate Professor, Markets, Public Policy and Law, Boston University Questrom School of Business

John F. Crowley, MBA, CEO,
BIO and Executive Chairman, Amicus Therapeutics

Steve Cutler, PhD

Mikael Dolsten, MD, PhD
Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer Inc.

Steve Frank
Chairman of Global Healthcare Investment Banking, JP Morgan

Ronny Gal, PhD
Chief Strategy and Growth Officer, Novartis

Levi Garraway, MD, PhD
EVP, Head of Global Product Development and CMO, Genentech

Keith Gottesdiener, MD
President & CEO, Prime Medicine

Steve Harr, MD
President and CEO, Sana Biotechnology

Fred Hassan
Managing Director, Healthcare, Warburg Pincus

Rachel Haurwitz, PhD
President & CEO, Caribou Biosciences

Colin Hill  
CEO & Co-Founder, Aitia Bio

Paul Hudson  
CEO, Sanofi

Eric Hughes, MD, PhD
EVP, Global R&D and Chief Medical Officer, Teva

Melanie Ivarsson, OBE, PhD, MBA
​​​​​​​Chief Development Officer, Moderna

Najat Khan, PhD
Chief Data Science Officer and Global Head Strategy & Operations, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson

Andy Lee  
SVP, Head of Global Clinical Trial Operations, Merck

Roger Longman
Founder & Chairman, Real Endpoints

Mathai Mammen, MD, PhD
CEO, FogPharma

Chronis Manolis, RPh
SVP, Pharmacy Services, Chief Pharmacy Officer, UPMC Insurance Services Division

Clive Meanwell, MD
Chairman and Partner, Population Health Partners

Bill Mezzanotte, MD, MPH
EVP, Head of R&D and Chief Executive Officer, CSL

Mark McKenna, MBA,
CEO, Mirador Therapeutics

Philip Needleman, MD, PhD
Professor and Chairman of Department of Pharmacology, Washington University School of Medicine, St Louis

Frank O. Nestle, MD, FMedSci
Global Head of Research and CSO, Sanofi

Karen Peterson
Patient Advocate

Andy Plump, MD, PhD
President, R&D, Takeda

Sylke Poehling, PhD
SVP and Global Head, Therapeutic Modalities, Pharma Research & Early Development, Roche

Sumant Ramachandra, MD, PhD
CEO & President, ImmPACT Bio

John Reed, MD, PhD
EVP, Innovative Medicine, R&D, Johnson & Johnson

David Reese, MD
EVP and Chief Technology Officer, Amgen

Alise Reicin, MD
CEO & President, Tectonic Therapeutics

Brent  Saunders, MBA
Chairman and CEO, Bausch + Lomb

Michael  Sherman, MD, MBA
Venture Partner, RA Ventures RA Capital Management

Mark Simon, MBA
Advisor, Stifel and Sun Pharmaceutical Industries, Inc
Alexandra Snyder, MD
Head of R&D and CMO, Generate Biomedicines

Badhri Srinivasan  
Head, Global Development Operations, Novartis

Mary Szela
CEO and President, TriSalus Life Sciences

Lambert van der Walde
SVP, Executive Director, Center for Health Care Research, UnitedHealth Group

Christopher Viehbacher
President and CEO, Biogen

Anne Wojcicki  
Co-Founder and CEO, 23&Me
George Yancopoulos, MD, PhD
Co-Founder, President & CSO, Regeneron

Tal Zaks, MD, PhD
Venture Partner, OrbiMed​​​​​​​

Elias Zerhouni, MD
Emeritus Professor, Johns Hopkins University

We are grateful for the support
​​​​​​​and participation from our past keynotes

Robert Bradway
CEO, Amgen

Robert M. Davis
Chairman and CEO, Merck

Joaquin Duato
CEO and Chairman of the Board, Johnson & Johnson
Deborah Dunsire, MD
Former CEO, Lundbeck

Kenneth Frazier
Chairman of the Board and CEO, Merck & Co

Scott Gottlieb, MD
23rd Commissioner, U.S. Food and Drug Administration
CNBC Contributor

Bahija Jallal, PhD
former CEO, MedImmune

Daphne Koller, PhD
Founder & CEO, insitro

​​​​​​​Vas Narasimhan, MD

CEO, Novartis

Lars Rebien Sorensen
former CEO, Novo Nordisk

Brent Saunders
CEO and chairman, Bausch + Lomb

Rupert Vessey, DPhil
Chief Scientist, Executive Partner, Flagship Pioneering 

Christopher Viehbacher
President and CEO, Biogen

George Yancopoulos, MD, PhD
Co-Founder, President & CSO, Regeneron

Many thanks to the executive team at ICON for all their support and to the entire speaking faculty, who brought their vast experience together to identify and collaborate over ideas that will advance therapeutics for the benefit of patients.

Our guests are as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change to advance R&D and to provide support for the leaders behind the movement.

For questions about the R&D Leadership Summit, ​​​​​​​please contact Tracey Kimball at Tracey@tcfllc.org or Valerie Bowling at Valerie@tcfllc.org.

image placeholder
image placeholder
image placeholder
image placeholder